235 related articles for article (PubMed ID: 27550886)
1. Colloids Versus Albumin in Large Volume Paracentesis to Prevent Circulatory Dysfunction: Evidence-based Case Report.
Widjaja FF; Khairan P; Kamelia T; Hasan I
Acta Med Indones; 2016 Apr; 48(2):148-55. PubMed ID: 27550886
[TBL] [Abstract][Full Text] [Related]
2. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
[TBL] [Abstract][Full Text] [Related]
3. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.
Bernardi M; Caraceni P; Navickis RJ; Wilkes MM
Hepatology; 2012 Apr; 55(4):1172-81. PubMed ID: 22095893
[TBL] [Abstract][Full Text] [Related]
4. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
Hamdy H; ElBaz AA; Hassan A; Hassanin O
J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
[TBL] [Abstract][Full Text] [Related]
5. Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute-on-Chronic Liver Failure.
Arora V; Vijayaraghavan R; Maiwall R; Sahney A; Thomas SS; Ali R; Jain P; Kumar G; Sarin SK
Hepatology; 2020 Sep; 72(3):1043-1055. PubMed ID: 31849085
[TBL] [Abstract][Full Text] [Related]
6. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Tan HK; James PD; Wong F
Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
Sola-Vera J; Miñana J; Ricart E; Planella M; González B; Torras X; Rodríguez J; Such J; Pascual S; Soriano G; Pérez-Mateo M; Guarner C
Hepatology; 2003 May; 37(5):1147-53. PubMed ID: 12717396
[TBL] [Abstract][Full Text] [Related]
8. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
Alessandria C; Elia C; Mezzabotta L; Risso A; Andrealli A; Spandre M; Morgando A; Marzano A; Rizzetto M
Dig Liver Dis; 2011 Nov; 43(11):881-6. PubMed ID: 21741331
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.
García-Compean D; Blanc P; Larrey D; Daures JP; Hirtz J; Mendoza E; Maldonado H; Michel H
Ann Hepatol; 2002; 1(1):29-35. PubMed ID: 15114293
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study.
Sersté T; Francoz C; Durand F; Rautou PE; Melot C; Valla D; Moreau R; Lebrec D
J Hepatol; 2011 Oct; 55(4):794-9. PubMed ID: 21354230
[TBL] [Abstract][Full Text] [Related]
11. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Singh V; Kumar R; Nain CK; Singh B; Sharma AK
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
[TBL] [Abstract][Full Text] [Related]
12. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study.
Singh V; Dheerendra PC; Singh B; Nain CK; Chawla D; Sharma N; Bhalla A; Mahi SK
Am J Gastroenterol; 2008 Jun; 103(6):1399-405. PubMed ID: 18547224
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.
Ginès A; Fernández-Esparrach G; Monescillo A; Vila C; Domènech E; Abecasis R; Angeli P; Ruiz-Del-Arbol L; Planas R; Solà R; Ginès P; Terg R; Inglada L; Vaqué P; Salerno F; Vargas V; Clemente G; Quer JC; Jiménez W; Arroyo V; Rodés J
Gastroenterology; 1996 Oct; 111(4):1002-10. PubMed ID: 8831595
[TBL] [Abstract][Full Text] [Related]
14. [Albumin infusion for paracentesis in patients with cirrhosis: dogma or evidence?].
Manzocchi S; Nendaz M; Spahr L
Rev Med Suisse; 2012 Oct; 8(358):1956, 1958-60. PubMed ID: 23198648
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis.
Shrestha DB; Budhathoki P; Sedhai YR; Baniya R; Awal S; Yadav J; Awal L; Davis B; Kashiouris MG; Cable CA
Ann Hepatol; 2021 Dec; 26():100547. PubMed ID: 34626828
[TBL] [Abstract][Full Text] [Related]
16. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
Singh V; Kumar B; Nain CK; Singh B; Sharma N; Bhalla A; Sharma AK
J Intern Med; 2006 Jul; 260(1):62-8. PubMed ID: 16789980
[TBL] [Abstract][Full Text] [Related]
17. The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction.
Elsabaawy MM; Abdelhamid SR; Alsebaey A; Abdelsamee E; Obada MA; Salman TA; Rewisha E
Clin Mol Hepatol; 2015 Dec; 21(4):365-71. PubMed ID: 26770925
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis.
Altman C; Bernard B; Roulot D; Vitte RL; Ink O
Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):5-10. PubMed ID: 9512946
[TBL] [Abstract][Full Text] [Related]
19. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis?
Bernardi M; Caraceni P; Navickis RJ
Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):191-192. PubMed ID: 28004601
[No Abstract] [Full Text] [Related]
20. Midodrine and albumin as a possible "winning pair" in managing paracentesis-induced circulatory dysfunction: a clinical case report.
Marigliano B; Internullo M; Scuro L; Tavanti A; Del Vecchio LR; Schito MB; Colombo GM; Guglielmelli E
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(24):9270-9274. PubMed ID: 36591858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
